A nanopore counter for highly sensitive evaluation of DNA methylation and its application in in vitro diagnostics
The Analyst · 2023
DOI: 10.1039/d3an00035d ↗Kurz gefasst
Fachartikel in der Zeitschrift The Analyst, 2023. Verfasst von Jiahai Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, School of Mechanical and Electrical Engineering, Guangzhou University, Guangzhou, 510006, China. daqich…. Hauptthemen laut MEDLINE: DNA Methylation, Nanopores. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A nanopore counter for highly sensitive DNA methylation evaluation was developed by relating the methylation level to the concentration of the generated fixed-length DNA duplex amplicons, which achieved a limit of detection of 0.61 aM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, School of Mechanical and Electrical Engineering, Guangzhou University, Guangzhou, 510006, China. daqichen@gzhu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, J., Chen, L., Gui, C., Zhu, J., Zhu, B., Zhu, Z., Li, Y., & Chen, D. (2023). A nanopore counter for highly sensitive evaluation of DNA methylation and its application in in vitro diagnostics. The Analyst. https://doi.org/10.1039/d3an00035d
Vancouver
Wang J, Chen L, Gui C, Zhu J, Zhu B, Zhu Z, et al. A nanopore counter for highly sensitive evaluation of DNA methylation and its application in in vitro diagnostics. The Analyst. 2023. doi:10.1039/d3an00035d
BibTeX
@article{Wang2023,
author = {Wang, Jiahai and Chen, Lanfang and Gui, Cenlin and Zhu, Jianji and Zhu, Baian and Zhu, Zhuobin and Li, Yunhui and Chen, Daqi},
title = {A nanopore counter for highly sensitive evaluation of DNA methylation and its application in in vitro diagnostics},
journal = {The Analyst},
year = {2023},
doi = {10.1039/d3an00035d}
}
EUVIMED